Cannabidiol (CBD) is one of the phytocannabinoids found in the cannabis plant. According to multiple scientific and medical sources, CBD has important medical benefits. Since 2013, the National Institutes of Health (PubMed) service has included over 1,100 studies on CBD in its index.
The U.S. Food and Drug Administration today approved the first generic versions of Abilify (aripiprazole). Generic aripiprazole is an atypical antipsychotic drug approved to treat schizophrenia and bipolar disorder. Alembic Pharmaceuticals Ltd., Hetero Labs Ltd., Teva Pharmaceuticals and Torrent Pharmaceuticals Ltd. have received FDA approval to market generic aripiprazole in multiple strengths and dosage forms.
A: Abilify is used for many different conditions such as schizophrenia, bipolar disorder and depression. The recommended starting dose for treating major depression (when used along with an antidepressant) in adults is 2 mg to 5 mg once daily.The effective dose is usually Abilify 5 to 10 mg once daily.: Abilify is an atypical antipsychotic and antidepressant used in the treatment of schizophrenia, bipolar disorder, and clinical depression. It has many reported side effects, but the less common ones include blurred vision, dry mouth, weight gain, stiffness, myalgia (muscle pain), and muscle spasms.